Cognition Therapeutics (CGTX) Change in Account Payables (2020 - 2022)
Cognition Therapeutics (CGTX) reported Change in Account Payables of -$5.0 million for Q4 2022, down 305.12% year-over-year from $2.4 million in Q4 2021, and down 204.77% on a QoQ basis from $4.8 million in Q3 2022.
Cognition Therapeutics (CGTX) has 3 years of Change in Account Payables data on file, last reported at -$5.0 million in Q4 2022.
- Quarterly Change in Account Payables fell 305.12% year-over-year to -$5.0 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was -$1.1 million (down 150.44% YoY) and the FY2022 annual result came in at -$1.1 million, down 150.44% from the prior year.
- Change in Account Payables declined to -$5.0 million in Q4 2022 per CGTX's latest filing, from $4.8 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $4.8 million in Q3 2022 and bottomed at -$5.0 million in Q4 2022.
- The 3-year median for Change in Account Payables is -$533000.0 (2021), against an average of $47000.0.
- Peak annual rise in Change in Account Payables reached 785.24% in 2022, while the deepest fall reached 305.12% in 2022.
- Tracing CGTX's Change in Account Payables over 3 years: stood at -$650000.0 in 2020, then jumped by 475.85% to $2.4 million in 2021, then tumbled by 305.12% to -$5.0 million in 2022.
- Per Business Quant, the three latest CGTX Change in Account Payables figures stand at -$5.0 million (Q4 2022), $4.8 million (Q3 2022), and -$693000.0 (Q2 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | -3.26 Mn |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | 35.60 Mn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | - |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | - |
| 10 | Cognition Therapeutics | 648,270.00 | 648,270.00 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -5.01 Mn |
| Dec 31, 2022 | -5.01 Mn |
| Sep 30, 2022 | 4.78 Mn |
| Sep 30, 2022 | 4.78 Mn |
| Jun 30, 2022 | -693,000.00 |
| Jun 30, 2022 | -693,000.00 |
| Mar 31, 2022 | -171,000.00 |
| Mar 31, 2022 | -171,000.00 |
| Dec 31, 2021 | 2.44 Mn |
| Dec 31, 2021 | 2.44 Mn |
| Sep 30, 2021 | -698,000.00 |
| Sep 30, 2021 | -698,000.00 |
| Jun 30, 2021 | -533,000.00 |
| Jun 30, 2021 | -533,000.00 |
| Mar 31, 2021 | 953,000.00 |
| Mar 31, 2021 | 953,000.00 |
| Dec 31, 2020 | -650,000.00 |
| Dec 31, 2020 | -650,000.00 |